SCHEMBL22480295

SCHEMBL22480295

O=C(CCN1CCOCC1)OCC(COCC(COC(=O)CCN1CCOCC1)(COC(=O)CCN1CCOCC1)COC(=O)CCN1CCOCC1)(COC(=O)CCN1CCOCC1)COC(=O)CCN1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 7/20 0.43
LMNA P02545 3/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 4/20 0.41
ATM Q13315 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
MPI P34949 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22480299 0.95 GLA (0.53) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL13384333 0.88 SMN1; SMN2 (0.47) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL16327978 0.87 SMN1; SMN2 (0.46) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL22480287 0.86 SMN1; SMN2 (0.48) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL10066874 0.84 ALDH1A1 (0.44) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL536194 0.83 SMN1; SMN2 (0.39) GLASMN1; SMN2ALDH1A1LMNAKMT2A
SCHEMBL6916351 0.83 SMN1; SMN2 (0.54) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL12120207 0.83 SMN1; SMN2 (0.54) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL13264768 0.83 GLA (0.50) GLASMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL13384335 0.82 SMN1; SMN2 (0.42) GLASMN1; SMN2ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200308425-A1 ACTIVE-ENERGY-RAY-CURABLE COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, COMPOSITION STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED MATERIAL, AND DECORATED ARTICLE TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2020-10-01 US disclosed